147 related articles for article (PubMed ID: 25372533)
21. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR
Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922
[TBL] [Abstract][Full Text] [Related]
22. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
Thobani A; Fishman GA
Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
[TBL] [Abstract][Full Text] [Related]
23. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Fishman GA; Apushkin MA
Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269
[TBL] [Abstract][Full Text] [Related]
24. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
Saraiva VS; Sallum JM; Farah ME
Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
[TBL] [Abstract][Full Text] [Related]
25. [Optical coherence tomography in the follow up of macular edema treatment in retinitis pigmentosa].
Rumen F; Souied E; Oubraham H; Coscas G; Soubrane G
J Fr Ophtalmol; 2001 Oct; 24(8):854-9. PubMed ID: 11894538
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.
Huang Q; Chen R; Lin X; Xiang Z
PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491
[TBL] [Abstract][Full Text] [Related]
27. Retinitis pigmentosa and other dystrophies.
Sahel J; Bonnel S; Mrejen S; Paques M
Dev Ophthalmol; 2010; 47():160-167. PubMed ID: 20703049
[TBL] [Abstract][Full Text] [Related]
28. RECURRENT CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH RETINITIS PIGMENTOSA TREATED WITH CARBONIC ANHYDRASE INHIBITORS.
Pomykala M; Rubin P; Rubin JS
Retin Cases Brief Rep; 2016; 10(3):205-7. PubMed ID: 26510001
[TBL] [Abstract][Full Text] [Related]
29. Macular cystoid spaces in patients with retinal dystrophy.
Lingao MD; Ganesh A; Karthikeyan AS; Al Zuhaibi S; Al-Hosni A; Al Khayat A; Capasso J; Trumler AA; Stroh E; Al Shekaili H; Cater JR; Levin AV
Ophthalmic Genet; 2016 Dec; 37(4):377-383. PubMed ID: 26894784
[TBL] [Abstract][Full Text] [Related]
30. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.
Iannaccone A; Fung KH; Eyestone ME; Stone EM
Am J Ophthalmol; 2009 Feb; 147(2):307-312.e2. PubMed ID: 18835469
[TBL] [Abstract][Full Text] [Related]
31. Retinitis pigmentosa and bilateral cystoid macular oedema in a patient heterozygous for the RIM1 mutation previously associated with cone-rod dystrophy 7.
Warwick AN; Shawkat F; Lotery AJ
Ophthalmic Genet; 2017; 38(2):178-182. PubMed ID: 27176872
[TBL] [Abstract][Full Text] [Related]
32. Long-term effect of acetazolamide in a patient with retinitis pigmentosa.
Chen JC; Fitzke FW; Bird AC
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1914-8. PubMed ID: 2211037
[TBL] [Abstract][Full Text] [Related]
33. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results.
Stanga PE; Downes SM; Ahuja RM; Chong NH; Antcliff R; Reck AC; Bird AC
Int Ophthalmol; 2001; 23(4-6):321-5. PubMed ID: 11944857
[No Abstract] [Full Text] [Related]
34. The role of carbonic anhydrase inhibitors in the management of macular edema.
Wolfensberger TJ
Doc Ophthalmol; 1999; 97(3-4):387-97. PubMed ID: 10896355
[TBL] [Abstract][Full Text] [Related]
35. Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study.
Giusti C; Forte R; Vingolo EM; Gargiulo P
Int Ophthalmol; 2001; 24(2):79-88. PubMed ID: 12201348
[TBL] [Abstract][Full Text] [Related]
36. Carbonic Anhydrase Inhibitor with Topical NSAID Therapy to Manage Cystoid Macular Edema in a Case of Gyrate Atrophy.
Piozzi E; Alessi S; Santambrogio S; Cillino G; Mazza M; Iggui A; Cillino S
Eur J Ophthalmol; 2017 Nov; 27(6):e179-e183. PubMed ID: 28708224
[TBL] [Abstract][Full Text] [Related]
37. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.
Whitcup SM; Csaky KG; Podgor MJ; Chew EY; Perry CH; Nussenblatt RB
Ophthalmology; 1996 Jul; 103(7):1054-62; discussion 1062-3. PubMed ID: 8684794
[TBL] [Abstract][Full Text] [Related]
38. Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation.
Schilling H; Heiligenhaus A; Laube T; Bornfeld N; Jurklies B
Retina; 2005; 25(2):182-8. PubMed ID: 15689809
[TBL] [Abstract][Full Text] [Related]
39. Management of Cystoid Macular Edema in Retinitis Pigmentosa.
Huckfeldt RM; Comander J
Semin Ophthalmol; 2017; 32(1):43-51. PubMed ID: 27748628
[TBL] [Abstract][Full Text] [Related]
40. [A case report of two patients with pseudophakia-associated macular edema: can OCT replace fluorescein angiography?].
Caramoy A; Fauser S; Kirchhof B; Liakopoulos S
Klin Monbl Augenheilkd; 2009 Oct; 226(10):849-51. PubMed ID: 19830641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
